quote-----------------
True but on the other side of the scale now is almost sure death of a patient...
----------------------
doesn't matter. ocean full of drugs have been to treat terminal cancers that went down the tubes because they didn't work in a full phase III trial. if drug shows to be working above the criteria set in the trial, it moves forwards as long as it is considered safe to take. If not, the drug is dead. At this point you, me, no one knows if it works.
And people won't know for quite a while. October news will not tell that. So company is burning around 15mil a qtr with well less than 45 mil cash due to 3rd qtr drain.
they will be out of money end of q2 2016, latest. What happens then, at best? More dilution.
And this doesn't not even consider the issue of the warrants.
News 
Market Data 
Discover 
